The sun is shining brightly on the Pharmalot corporate campus this morning. As we ready our daily cup of stimulation, we are also readying more interesting items. Meanwhile, though, it is time to catch up. So grab your own cup and, before you head into another meeting or hunker down to meet that deadline, take a look at these...
Glaxo's Treximet Migraine Pill Gets FDA Approval (MarketWatch)
No Brain Problems Reported With Tysabri (The Wall Street Journal)
EMD Serono Plans $50M Expansion In Boston (The Boston Globe)
AstraZeneca May Seek More Alliances (MarketWatch)
Sanofi-Pasteur Plans $100M Expansion In Toronto (Canadian Press)
Iomai Gets Go-Ahead For Bird Flu Patch (Yahoo/Reuters)